While everyone is distracted by arguments of whether Turbo Cancer exists, Big Pharma is in a feeding frenzy of Cancer Treatment company acquisitions: I review the biggest blockbuster buyouts and mergers in past 4 months: Pfizer spent $43 billion to acquire Seagen (paid 42% premium)- doubles Pfizer's Oncology pipeline
- will be able to treat majority of Turbo Cancers
- spent $14 million on SuperBowl Ad
- has 10 manufacturing sites on 3 continents to produce cancer drugs
- promises to produce 8 blockbuster cancer drugs by 2030
- will use ADCs (synthetic antibody drug conjugates) Johnson & Johnson spent $2 billion to buy Ambrx (completed Mar.7, 2024)- will use ADCs (synthetic antibody drug conjugates) just like Pfizer
- has a "oncology innovation strategy" AbbVie spent $10.1 billion to buy Immunogen at 95% premium.- expands their oncology pipeline (ovarian cancer)
- wants to re-define standard of care for those "living with cancer"
- to drive revenue growth into next decade
https://blog.creaders.net/u/8994/202401/480676.html
传达中共中央电视台今日重要批示
举报境内跟帖反华煽颠
我爹炼油厂被击中爆燃
|